prindi

Effects of alirocumab on cardiovascular events after coronary bypass surgery

autor
Goodman, Shaun G.
Aylward, Philip E.
Szarek, Michael
Viigimaa, Margus
vastutusandmed
Goodman, Shaun G.; Aylward, Philip E.; Szarek, Michael; Chumburidze, Vakhtang; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J. Wouter; Kedev, Sasko; Letierce, Alexia; Moryusef, Angele; Pordy, Robert; Lopez, Gabriel Arturo Ramos; Roe, Matthew T.; Viigimaa, Margus et al.
allikas
Journal of the American College of Cardiology
ajakirja aastakäik number kuu
vol. 74, 9
ilmumisaasta
2019
leheküljed
p. 1177−1186 : ill
leitav
https://doi.org/10.1016/j.jacc.2019.07.015
märksõna
kolesterool
ravimid
koronaararterid
südame-veresoonkonna haigused
lipiidid
biokeemilised aspektid
võtmesõna
alirocumab
cholesterol
coronary artery bypass graft
lipids
proprotein convertase subtilisin−kexin type (9PCSK9)
ISSN
0735-1097
märkused
Includes bibliogr
TTÜ struktuuriüksus
tervisetehnoloogiate instituut
keel
inglise
Goodman, S.G., Aylward, P.E., Szarek, M., Viigimaa, M. et al. Effects of alirocumab on cardiovascular events after coronary bypass surgery // Journal of the American College of Cardiology (2019) vol. 74, 9, p. 1177−1186 : ill. https://doi.org/10.1016/j.jacc.2019.07.015